Custom Health Holdings Inc. News Releases

Custom Health Completes Acquisition of Spencer Health Solutions, Bringing In-Home Medication Dispensing Technology Fully In-House

Tue, 08 Sep 2026 06:00:00 -0400

Effective September 4, 2026, Custom Health has completed its previously announced acquisition of Spencer Health Solutions, developer of the spencer® smart medication dispenser and in-home monitoring platform, giving the Company full ownership of the spencer® technology, intellectual property, and product roadmap.Spencer now operates as a wholly owned subsidiary of Custom Health, eliminating third-party support, infrastructure, and device costs previously incurred under Custom Health's prior...

Custom Health Achieves 70% Increase in Quarterly Revenue in Q2-2026 and Advances Medication Management Platform with Evergreen Pharmacy and Spencer Health Solutions Acquisitions

Mon, 17 Aug 2026 18:07:00 -0400

For the three months ended June 30, 2026, Custom Health achieved quarterly revenue of US$7.4 million, an increase of 70% from Q2-2025. The results reflect the acquisition of InnovativeRx during the period. The equity pickup for IRX accounts for an acquisition date of June 5, 2026. Proforma Revenue for the combined entity for the 3 months ended June 30, 2026 is US$14.3 million(1).Subsequent to quarter-end, Custom Health entered into a binding letter of intent to acquire Evergreen Pharmacy LLC...

Custom Health to Acquire Spencer Health Solutions, Strengthening Its Medication Management Infrastructure at Home

Wed, 05 Aug 2026 06:00:00 -0400

Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer® in-home smart dispensing and monitoring system, bringing an important in-home medication technology capability fully in-house and further strengthening Custom Health's medication management at home.The Transaction is expected to expand the Corporation's margins by eliminating third-party support and...

Custom Health Announces Binding Letter of Intent to Acquire Evergreen Pharmacy; Expected to Add Over US$78 Million in Annual Revenue

Wed, 22 Jul 2026 06:30:00 -0400

Custom Health has entered into a binding letter of intent (the "LOI") to acquire Evergreen Pharmacy LLC ("Evergreen"), a Wisconsin-based specialty pharmacy specializing in the management of complex therapies for chronic disease states.Evergreen generated Revenue of approximately US$78.8 million with Normalized EBITDA (1) of US$0.60 million, for the twelve-month period ended December 31, 2025. Evergreen is a profitable company on both EBITDA and Net Income basis and would be immediately...

Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026

Fri, 03 Jul 2026 06:00:00 -0400

For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting total consolidated quarterly revenue of US$12.9 million and proforma annualized revenue run-rate(1) of US$51.6 million.Custom Health successfully completed its public listing and started trading on the Toronto Stock Exchange on June 24, 2026 under the symbol CHLT, significantly enhancing the...

Custom Health Announces Strategic Leadership Appointments to Support Continued Growth and Regulatory Excellence

Thu, 25 Jun 2026 06:30:00 -0400

Robert Guzman has been appointed Chief Compliance & Regulatory Officer, bringing extensive experience in regulatory oversight, compliance management, and quality assurance to strengthen Custom Health's governance framework and support the Company's continued expansion across highly regulated healthcare and pharmacy markets.Brent Herman, Founder, President and Chief Executive Officer of InnovativeRx US Holdings, Inc., has been appointed Executive Vice President, Corporate Development, bringing...

Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange

Mon, 22 Jun 2026 17:45:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Custom Health Holdings Inc. (TSX: CHLT) (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated June 5, 2026, is pleased to announce that it has received final approval for listing on the Toronto Stock Exchange (the "TSX"). The common shares of the Company (CUSIP 23204J104 / ISIN CA23204J1049) ("Common Shares") will commence trading on the TSX under the symbol "CHLT" at market open on...

Custom Health Announces Closing of the Acquisition of InnovativeRx Operating Subsidiaries to Expand Integrated Medication Management Infrastructure Across North America

Wed, 10 Jun 2026 07:00:00 -0400

Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US Holdings, Inc. ("InnovativeRx") to expand its integrated healthcare infrastructure across North America. InnovativeRx is an existing operational partner already utilizing Custom Health's proprietary AdhereNet® platform, enabling streamlined integration and workflow continuity.Financial information: The InnovativeRx acquisition is expected to be immediately...

Custom Health Holdings Inc. Announces Completion of Plan of Arrangement

Fri, 05 Jun 2026 18:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Custom Health Holdings Inc. (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated May 13, 2026, is pleased to announce the successful completion of its previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") with Custom Health, Inc. ("Custom Delaware"), pursuant to which, among other things, Custom Health has acquired 100% of...

Custom Health Announces Appointment of Chief Financial Officer and Board of Directors and Shareholder Approval for Proposed Public Listing

Thu, 14 May 2026 07:00:00 -0400

Jason Nalewany has been appointed as Chief Financial Officer of Custom Health and, following the completion of the Arrangement, the Resulting Issuer. Jason will support both companies by providing public company compliance, financial reporting, capital allocation and long-term growth strategy.The Resulting Issuer and the operations of Custom Health will be supported by an experienced Board of Directors that bring deep expertise across healthcare, technology, capital markets and governance to the...